Αποτελέσματα Αναζήτησης
Revolutionary infusion pump technology based on pneumatics rather than mechanics with huge safety / clinical / economic benefits for payors, providers, patients. Cardinal Partners is founding investor providing regulatory planning, investor syndicate and strategic partnering.
- Team
Team. The operating and investment backgrounds of the...
- Companies
Cardinal Partners is lead investor, raising capital and IPO...
- Our Vision
The transition from paper to digital combined with machine...
- Contact
Princeton Office (HQ) 230 Nassau Street, Princeton, NJ 08542...
- Venture Partners
Venture Partners; Venture Partners Together we can achieve...
- John Clarke
John Clarke has a 35 year record of early-stage venture...
- Thomas Mckinley
Thomas McKinley has over 35 years of venture capital...
- Events
© 2019 Cardinal Partners. All rights reserved. Scroll to top
- Team
Cardinal Partners has extensive experience in starting, incubating and investing in early stage healthcare technology-enabled services and life sciences companies.
Cardinal Partners is a venture capital partnership focused exclusively on healthcare investing.
Founded in 1996, Cardinal Partners is a venture capital firm based in Princeton, New Jersey. The firm prefers to invest in the healthcare, consumer, machine learning, blockchain, technology, and life sciences sectors. This firm is a Registered Investment Adviser (RIA).
John Clarke has a 35 year record of early-stage venture capital investment success. John co-founded Cardinal Partners in 1997 and currently serves as a Managing Partner of the firm. John leads Cardinal’s life sciences investment efforts and has had an extraordinary record of success.
Team. The operating and investment backgrounds of the Cardinal’s Principals are the basis for longstanding relationships within diverse communities including hospitals and other providers, biotechnology scientists, researchers and business leaders, medical device companies, and IT system providers.
VC investing group Cardinal Partners provides capital to innovative tech companies.